[1]
T. Perekhrestenko, U. Melnyk, N. Goryainova, and I. Diagil, “Expression of Ki-67 and CD34 on blood and bone marrow cells of CML patients with different response to imatinib and nilotinib therapy”, Exp. oncol., vol. 42, no. 2, pp. 144–147, Jun. 2023.